StockDriftsStockDriftsTop 27 Propel Bio Management LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| PAGP | PLAINS GP HOLDINGS LP-CL | 16.16% | 1.27M | $30.9M | +0.00%(+0) | $16.04(+57.09%) | 2026-06-30 | |
| ACHV | ACHIEVE LIFE SCIENCES INC | 13.79% | 4.03M | $26.3M | +6.54%(+247.59K) | $3.07(+132.40%) | 2026-06-30 | |
| CORT | CORCEPT THERAPEUTICS INC | 6.21% | 136.5K | $11.9M | -7.66%(-11.33K) | $37.56(+197.14%) | 2026-06-30 | |
| PHAT | PHATHOM PHARMACEUTICALS I | 5.96% | 1.05M | $11.4M | +24.85%(+209.09K) | $11.16(-19.18%) | 2026-06-30 | |
| DCTH | DELCATH SYSTEMS INC | 5.74% | 871.5K | $11.0M | -11.05%(-108.24K) | $10.87(+56.47%) | 2026-06-30 | |
| MIST | MILESTONE PHARMACEUTICALS | 5.21% | 7.43M | $10.0M | +80.40%(+3.31M) | $1.53(-29.26%) | 2026-06-30 | |
| CMPS | COMPASS PATHWAYS PLC | 4.24% | 573.1K | $8.1M | -22.77%(-168.96K) | $5.16(+171.06%) | 2026-06-30 | |
| KYTX | KYVERNA THERAPEUTICS INC | 4.12% | 883.2K | $7.9M | +37.05%(+238.78K) | $7.85(+4.11%) | 2026-06-30 | |
| ARTV | ARTIVA BIOTHERAPEUTICS IN | 3.54% | 696.4K | $6.8M | +375.81%(+550.07K) | $7.11(+60.26%) | 2026-06-30 | |
| ABEO | ABEONA THERAPEUTICS INC | 3.18% | 983.1K | $6.1M | -26.08%(-346.83K) | $5.32(+22.55%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (10 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | +15.48% |
| Top 20 Holdings Unweighted | — | — | — | — | +1.20% |
Propel Bio Management LLC reports $191.09M in US-listed equity holdings across 29 positions in its most recent 13F filing. Its largest disclosed positions are PAGP (16.2%), ACHV (13.8%) and CORT (6.2%). The top 20 holdings account for 89.95% of reported assets. Its disclosed equity book has returned +15.48% cumulatively over 10 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Propel Bio Management LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Propel Bio Management LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1969764). View Propel Bio Management LLC’s 13F filings on SEC